Photodynamic therapy for high-grade dysplasia in Barrett's esophagus

Techniques in Gastrointestinal Endoscopy

Volumn 7, Issue 2 SPEC. ISS., 2005, Pages 60-65

  Barr, Hugh ^a  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Barrett's esophagus; Dysplasia; Photodynamic therapy

Indexed keywords

PHOTOFRIN; PRODRUG; PROTON PUMP INHIBITOR;

ARTICLE; BARRETT ESOPHAGUS; CANCER INHIBITION; CANCER INVASION; CANCER STAGING; CATHETER ABLATION; COMPARATIVE STUDY; DISEASE SEVERITY; DRUG ABSORPTION; DYSPHAGIA; DYSPLASIA; EARLY CANCER; EPITHELIZATION; ERADICATION THERAPY; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; ESOPHAGUS DYSPLASIA; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; HUMAN; LIVER DISEASE; LIVER FUNCTION; NAUSEA; PHENOTYPE; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRECANCER; THORAX DISEASE;

EID: 20444464875     PISSN: 10962883     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tgie.2005.02.002     Document Type: Article

References (37)

1. J.F. Kasting The rise of atmospheric oxygen Science 293 2001 819-820
2. H. Barr C. Kendall J. Reyes-Goddard et al. Clinical aspects of photodynamic therapy Sci Prog 85 2002 131-150
3. D. Moreira H. Le Guyader H. Phillippe The origin of red algae and the evolution of chloroplasts Nature 405 2000 69-72
4. H. Barr A.J. Dix C. Kendall et al. The potential for photodynamic therapy in the management of Upper Gastrointestinal Disease Aliment Pharmacol Ther 15 2001 311-321
5. J.S. McCaughan W. Hicks L. Laufman et al. Palliation of esophageal malignancy with photoradiation therapy Cancer 54 1984 2905-2910
6. R.J. Schlemper R.H. Riddell Y. Kato et al.The Vienna classification of gastrointestinal epithelial neoplasia Gut 47 2000 251-255
7. E. Montgomery M.P. Bronner J.R. Goldblum et al. Reproducibility of the diagnosis of dysplasia in Barrett's oesophagus: A reaffirmation Hum Path 32 2001 268-378
8. A.H. Ormsby R.E. Petras Henricks et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma Gut 51 2002 671-676
9. H. Barr R.C. Fitzgerald Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer Gut 52 2003 14-17
10. T.G. Schnell S.J. Sontag G. Chejfec et al. Long term non-surgical management of Barrett's esophagus with hig-grade dysplasia Gastroenterology 120 2001 1607-1619
11. M.A. Kara J.J. Bergman G.N.J. Tytgat Follow-up for high-grade dysplasia in Barrett's oesophagus Gastrointest Endosc Clin N Am 13 2003 513-533
12. J.M. Collard High-grade dysplasia in Barrett's esophagus. The case for oesophagectomy Chest Surg Clin N Am 12 2002 77-92
13. E. Montgomery J.R. Goldblum J.K. Greenson et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: A follow-up study based on 138 cases from diagnostic variability study Hum Path 32 2001 379-388
14. R. Ouata-Lascar R.C. Fitzgerald G. Triadafilopoulos Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression Gastroenterology 117 1999 327-335
15. W. Hameeteman G.N. Tytgat H.F. Houthoff et al. Barrett's oesophagus development and adenocarcinoma Gastroenterology 96 1989 1249-1256
16. T. Bailey L. Biddlestone N. Sheherd et al. Altered Cadherin and Catenin Complex's in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with dedifferentiation and epithelial-mesenchymal transition Am J Pathol 152 1998 1-10
17. R. Ackroyd N.J. Brown T.J. Stephenson et al. Ablation treatment for Barrett oesophagus: What depth of tissue destruction is needed J Clin Pathol 52 1999 509-512
18. R.A. Coad P.J. Warner H. Barr et al. On the genesis of Barrett's oesophagus: A three dimensional study of the relationship between oesophageal gland ducts, Barrett's oesophagus and associated squamous islands Br J Cancer 91 2004 P105
19. H. Barr Barrett's esophagus: Treatment with 5-aminolevulinic acid photodynamic therapy Gastrointest Endosc Clin N Am 10 2000 421-438
20. N. Stone Standardizing Dosimetry in esophageal PDT: An argument for use of centering devices and removal of misleading units Technol Cancer Res Treat 2 2003 76-84
21. L. Gossner M. Stolte R. Stroke et al. Photodynamic therapy of high-grade dysplasia and early stage carcinomas by means of 5-aminolaevulinic acid Gastroenterology 114 1998 447-455
22. H. Barr W.C. Tan N.A. Shepherd Photodynamic therapy (PDT) using 5-aminolaevulinic acid (5-ALA) for oesophageal adenocarcinoma associated with Barrett's metaplasia Lasers Med Sci 4 1997 3
23. H. Barr N.A. Shepherd A. Dix et al. Eradication of high grade dysplasia in columnar-lined (Barrett's) oesophagus using photodynamic therapy with endogenously generated protoporphyrin IX Lancet 348 1996 584-585
24. W.C. Tan C. Fulljames N. Stone et al. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia J Photochem Photobiol B Biol 53 1999 75-80
25. L.R. Biddlestone C.P. Barham S.P. Wilkinson et al. The histopathology of treated Barrett's esophagus Am J Surg Pathol 22 1998 239-245
26. R. Ackroyd N.J. Brown M.F. Davis et al. Photodynamic therapy for dysplastic Barrett's oesophagus: A prospective, double blind, randomised, placebo-controlled trial Gut 47 2000 613-617
27. K. Krishnadath K.K. Wang W. Liu et al. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy Gastroenterology 119 2000 624-630
28. B.F. Overholt M. Panjehpour D.L. Halberg Photodynamic therapy of Barrett's oesophagus with dysplasia and/or early stage carcinoma long-term results Gastrointest Endosc 58 2003 193-198
29. A. Sibille R. Lambert J.-C. Souquet et al. Long-term survival after photodynamic therapy for esophageal cancer Gastroenterology 108 1995 337-344
30. T. Patrice M.T. Foultier S. Yactayo et al. Endoscopic photodynamic therapy with hematoporphyrin Derivative for primary treatment of gastrointestinal neoplasms in inoperable patients Dig Dis Sci 35 1990 545-552
31. L. Corti J. Skarlatos C. Boso et al. Outcome of patients receiving photodynamic therapy for early esophageal cancer Int J Radiat Oncol Biol Phys 47 2000 419-424
32. L. Gossner A. May O. Pech et al. Photodynamic therapy of Barrett's esopagus with dysplasia or early cancer Gastroenterology 116 1999 (abstr G1811)
33. B. Javaid P. Watt N. Krasner Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin) a preliminary study Lasers Med Sci 17 2002 51-56
34. K. Ragunath N. Krasner V.S. Raman et al. Endoscopic ablation of dysplastic barrett's oesophagus comparing Argon Plasma Coagulation and Photodynamic therapy short term results of a randomized prospective trial Lasers Med Sci 2005 (in press)
35. M. Hage P.D. Sieresma H. van Dekken et al. 5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus a randomised trial Gut 53 2004 785-790
36. C.J. Kelty R. Ackroyd N.J. Brown Endoscopic ablation of Barrett's oesophagus a randomised controlled trial of photodynamic therapy vs argon plasma coagulation Br J Sci 91 2004 (abstr 42)
37. B.F. Overholt C.J. Lightdale K. Wang et al. International Multicenter Partially Blinded Randomised Study of the efficacy of photodynamic therapy (PDT) using Porfimer Sodium (POR) for the ablation of high-grade dysplasia (HGD) in Barrett's esophagus (BE) results of 24 month follow-up Gastroenterology 124 2003 (abstr A20)